Are vegans being overlooked in our prescribing practices: An orthopaedic perspective from Bristol, United Kingdom.
Level 5 - mechanism / opinion, no new human data
Narrative review and formulary overview without systematic review methodology.
PubMed 37817761 · doi:10.1016/j.jcot.2023.102250
What was done
The authors reviewed the British National Formulary (BNF), local hospital pharmacy guidelines, and online Summaries of Product Characteristics (SPCs) to identify content of animal origin (CAO) in medications commonly used in trauma and orthopaedics, assessed UK COVID-19 vaccines for CAO, and identified potential non-animal alternatives.
What was found
The abstract reports qualitative formulary findings without numerical trial data: standard unfractionated heparin is porcine-derived (fondaparinux is an alternative); cholecalciferol (vitamin D3) is manufactured using lanolin from sheep's wool (ergocalciferol/vitamin D2 is a non-animal alternative); propofol contains egg proteins; and widely available UK COVID-19 vaccines are free of animal products.
Why it matters
Clinicians infrequently consider animal-derived excipients or active ingredients, but understanding which medications contain animal products allows providers to offer alternatives that respect patient dietary, ethical, or religious preferences.
Limits
This is a narrative review with no primary patient data, quantitative outcomes, or systematic literature search methodology. Findings are specific to UK pharmaceutical formulations and SPCs, which may not generalize to other countries where drug manufacturing sources differ.
Cited by
- supports Supplemental vitamin D3 is commonly derived from lanolin excreted by sheep sebaceous glands.